A randomised, double-blind, parallel-group trial to investigate the efficacy and tolerability of radiotherapy as prophylactic treatment against the development of CASODEX monotherapy induced gynaecomastia and breast pain in prostate cancer patients.

Study identifier:7054IL/0038

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A randomised, double-blind, parallel-group trial to investigate the efficacy and tolerability of radiotherapy as prophylactic treatment against the development of CASODEX monotherapy induced gynaecomastia and breast pain in prostate cancer patients.

Medical condition

prostate cancer

Phase

Phase 3

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Nov 1999
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria